All lobbying filings
MANATT, PHELPS, AND PHILLIPS
Lobbying for DENALI THERAPEUTICS · Biopharmaceutical Company
Filing
2nd Quarter - Report
Lobbying activity
1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development